Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 30, 2021

Monogenic diabetes in Pakistani infants and children: challenges in a resource poor country

  • Mohsina Noor Ibrahim ORCID logo EMAIL logo , Taj Muhammad Laghari , Miara Riaz , Zubair Khoso , Yasir Naqi Khan , Mehar Yasir , Misbah Iqbal Hanif ORCID logo EMAIL logo , Sarah E. Flanagan , Elisa De Franco and Jamal Raza

Abstract

Objectives

To review the data of infants and children with suspected monogenic diabetes who underwent genetic testing.

Methods

Monogenic diabetes is a rare form of diabetes resulting from mutations in a single gene. It can be caused by dominant as well as recessive modes of inheritance. In a country like Pakistan where interfamily marriages are common the incidence of genetic disorders is increased. As Pakistan a resource-poor country, the diagnosis of insulin-dependent diabetes is often delayed and a genetic diagnosis of monogenic diabetes is extremely difficult. Children with clinical diagnosis of monogenic and syndromic diabates were recruited and blood samples were sent for genetic analysis.

Results

One thousand sixty four new cases diagnosed with type 1 diabetes were registered at the National Institute of Child Health, Karachi, in the last 10 years. Of these 39 patients were selected for genetic testing who were diagnosed with diabetes/had a sibling diagnosed with diabetes before the age of nine months (n = 27) or had extra pancreatic features ( n= 12). We identified mutations in 18/27 cases diagnosed with diabetes before nine months of age. The most common genetic subtype was WolcottRallison syndrome caused by EIF2AK3 mutations (seven cases). KCNJ11 mutations were identified in two cases, ABCC8mutations were identified in four cases from three families, GCK and INS mutations were each identified in two cases, and one SLC2A2 mutation was identified in one case. A genetic diagnosis was made in 12/12 children from six families with diabetes diagnosed after the age of nine months who had extrapancreatic features. Six patients had genetically confirmed Wolfram syndrome (WFS1), three had thiamine-responsive megaloblastic anemia (SLC19A2) and three were diagnosed with histocytosis lymphadenopathy plus syndrome (SLC29A3).

Conclusions

Genetic testing is essential to confirm a diagnosis of monogenic diabetes which guides clinical management and future counselling. Our study highlights the importance of diagnosing monogenic diabetes in the largely consanguineously-married population of Pakistan.


Corresponding authors: Mohsina Noor Ibrahim, MBBS, DCH, FCPS, Professor of Peadeatrics, Peadiatric Endocrinologist, National Institute of Child Health, Karachi, Pakistan, E-mail: ; and Misbah Iqbal Hanif, PhD, Clinical Geneticist, National Institute of Child Health, Karachi, Pakistan, E-mail:

  1. Research funding: No research funding was granted.

  2. Author contributions: The author Mohsina Noor Ibrahim is the main author and principal investigator of this study. And all the authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: There is no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Hattersley, AT, Greeley, SA, Polak, M, Rubio-Cabezas, O, Njølstad, PR, Mlynarski, W, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2018;19:47–63. https://doi.org/10.1111/pedi.12772.Search in Google Scholar

2. Iafusco, D, Massa, O, Pasquino, B, Colombo, C, Iughetti, L, Bizzarri, C, et al.. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1: 90,000 live births. Acta Diabetol 2012;49:405–8. https://doi.org/10.1007/s00592-011-0331-8.Search in Google Scholar

3. Wiedemann, B, Schober, E, Waldhoer, T, Koehle, J, Flanagan, SE, Mackay, DJ, et al.. Incidence of neonatal diabetes in Austria–calculation based on the Austrian diabetes register. Pediatr Diabetes 2010;11:18–23. https://doi.org/10.1111/j.1399-5448.2009.00530.x.Search in Google Scholar

4. Eid, HA, Ali, MI, Hattersley, AT, Hussain, K, Ellard, S. Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr Diabetes 2012;13:499–505.10.1111/j.1399-5448.2011.00828.xSearch in Google Scholar PubMed

5. Saraswathi, S, Al-Khawaga, S, Elkum, N, Hussain, K. A systematic review of childhood diabetes research in the Middle East region. Front Endocrinol 2019;10:805. https://doi.org/10.3389/fendo.2019.00805.Search in Google Scholar

6. Ellard, S, Allen, HL, De Franco, E, Flanagan, SE, Hysenaj, G, Colclough, K, et al.. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 2013;56:1958–63. https://doi.org/10.1007/s00125-013-2962-5.Search in Google Scholar

7. Møller, AM, Dalgaard, LT, Pociot, F, Nerup, J, Hansen, T, Pedersen, O. Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having type I diabetes. Diabetologia 1998;41:1528–31. https://doi.org/10.1007/s001250051101.Search in Google Scholar

8. Lambert, AP, Ellard, S, Allen, LI, Gallen, IW, Gillespie, KM, Bingley, PJ, et al.. Identifying hepatic nuclear factor 1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003;26:333–7. https://doi.org/10.2337/diacare.26.2.333.Search in Google Scholar

9. Rubio-Cabezas, O, Edghill, EL, Argente, J, Hattersley, AT. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes. Diabet Med 2009;26:1070–4. https://doi.org/10.1111/j.1464-5491.2009.02812.x.Search in Google Scholar

10. Awa, WL, Schober, E, Wiegand, S, Herwig, J, Meissner, T, Schmidt, F, et al.. Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. Diabetes Res Clin Pract 2011;94:463–7. https://doi.org/10.1016/j.diabres.2011.09.011.Search in Google Scholar

11. Bergmann, AK, Sahai, I, Falcone, JF, Fleming, J, Bagg, A, Borgna-Pignati, C, et al.. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J Pediatr 2009;155:888–92. https://doi.org/10.1016/j.jpeds.2009.06.017.Search in Google Scholar

12. Delépine, M, Nicolino, M, Barrett, T, Golamaully, M, Lathrop, GM, Julier, C. EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000;25:406–9. https://doi.org/10.1038/78085.Search in Google Scholar

13. Senée, V, Vattem, KM, Delépine, M, Rainbow, LA, Haton, C, Lecoq, A, et al.. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004;53:1876–83. https://doi.org/10.2337/diabetes.53.7.1876.Search in Google Scholar

14. Habeb, AM. Frequency and spectrum of Wolcott-Rallison syndrome in Saudi Arabia: a systematic review. Libyan J Med 2013;8:21137. https://doi.org/10.3402/ljm.v8i0.21137.Search in Google Scholar

15. Rubio-Cabezas, O, Patch, AM, Minton, JA, Flanagan, SE, Edghill, EL, Hussain, K, et al.. Wolcott–Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009;94:4162–70. https://doi.org/10.1210/jc.2009-1137.Search in Google Scholar

16. Abbasi, F, Habibi, M, Enayati, S, Bitarafan, F, Razzaghy-Azar, M, Sotodeh, A, et al.. A genotype-first approach for clinical and genetic evaluation of Wolcott-Rallison syndrome in a large cohort of Iranian children with neonatal diabetes. Can J Diabetes 2018;42:272–5. https://doi.org/10.1016/j.jcjd.2017.06.009.Search in Google Scholar

17. Habeb, AM, Flanagan, SE, Deeb, A, Al-Alwan, I, Alawneh, H, Balafrej, AA, et al.. Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans. Arch Dis Child 2012;97:721–3. https://doi.org/10.1136/archdischild-2012-301744.Search in Google Scholar

18. Deeb, A, Habeb, A, Kaplan, W, Attia, S, Hadi, S, Osman, A, et al.. Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the Emirate of AbuDhabi, United Arab Emirates. Am J Med Genet 2016;170:602–9. https://doi.org/10.1002/ajmg.a.37419.Search in Google Scholar

19. De Franco, E, Flanagan, SE, Houghton, JA, Allen, HL, Mackay, DJ, Temple, IK, et al.. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet 2015;386:957–63. https://doi.org/10.1016/s0140-6736(15)60098-8.Search in Google Scholar

20. Khan, SA, Parkash, A, Ibrahim, M. Permanent neonatal diabetes (DEND syndrome). J Coll Phys Surg Pakistan 2016;26:114.Search in Google Scholar

21. Garin, I, Edghill, EL, Akerman, I, Rubio-Cabezas, O, Rica, I, Locke, JM, et al.. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci USA 2010;107:3105–10. https://doi.org/10.1073/pnas.0910533107.Search in Google Scholar

22. Edghill, EL, Flanagan, SE, Patch, AM, Boustred, C, Parrish, A, Shields, B, et al.. Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008;57:1034–42. https://doi.org/10.2337/db07-1405.Search in Google Scholar

23. Osbak, KK, Colclough, K, Saint‐Martin, C, Beer, NL, Bellanné‐Chantelot, C, Ellard, S, et al.. Update on mutations in glucokinase (GCK), which cause maturity‐onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009;30:1512–26. https://doi.org/10.1002/humu.21110.Search in Google Scholar

24. Khandelwal, P, Sinha, A, Jain, V, Houghton, J, Hari, P, Bagga, A. Fanconi syndrome and neonatal diabetes: phenotypic heterogeneity in patients with GLUT2 defects. CEN Case Rep 2018;7:1–4. https://doi.org/10.1007/s13730-017-0278-x.Search in Google Scholar

25. Amr, S, Heisey, C, Zhang, M, Xia, XJ, Shows, KH, Ajlouni, K, et al.. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet 2007;81:673–83. https://doi.org/10.1086/520961.Search in Google Scholar

26. Rogers, LE, Porter, FS, Sidbury, JBJr. Thiamine-responsive megaloblastic anemia. J Pediatr 1969;74:494–504. https://doi.org/10.1016/s0022-3476(69)80031-4.Search in Google Scholar

27. Astuti, D, Sabir, A, Fulton, P, Zatyka, M, Williams, D, Hardy, C, et al.. Monogenic diabetes syndromes. Hum Mutat 2017;38:764–77. https://doi.org/10.1002/humu.23233.Search in Google Scholar

28. Pallotta, MT, Tascini, G, Crispoldi, R, Orabona, C, Mondanelli, G, Grohmann, U, et al.. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med 2019;17:238. https://doi.org/10.1186/s12967-019-1993-1.Search in Google Scholar

29. Neufeld, EJ, Mandel, H, Raz, T, Yandava, CN, Szargel, R, Stagg, A, et al.. Localization of the gene for the syndrome of thiamine-responsive megaloblastic anemia with diabetes and deafness to chromosome 1q23 by homozygosity mapping. Am J Hum Genet 1997;61:A14. 5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA: UNIV CHICAGO PRESS. https://doi.org/10.1086/301642.Search in Google Scholar

30. Askari, S, Ibrahim, M, Raza, J, Fawwad, A, Basit, A. Frameshift variance in SLC19A2 gene causing thiamine responsive megaloblastic anemia (TRMA): a case report from Pakistan. Int J Diabetes Dev Ctries 2020;40:1–3.10.1007/s13410-020-00797-5Search in Google Scholar

31. Molho-Pessach, V, Lerer, I, Abeliovich, D, Agha, Z, Libdeh, AA, Broshtilova, V, et al.. The H syndrome is caused by mutations in the nucleoside transporter hENT3. Am J Hum Genet 2008;83:529–34. https://doi.org/10.1016/j.ajhg.2008.09.013.Search in Google Scholar

32. Molho-Pessach, V, Agha, Z, Aamar, S, Glaser, B, Doviner, V, Hiller, N, et al.. The H syndrome: a genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations. J Am Acad Dermatol 2008;59:79–85. https://doi.org/10.1016/j.jaad.2008.03.021.Search in Google Scholar

33. Picarsic, J, Pysher, T, Zhou, H, Fluchel, M, Pettit, T, Whitehead, M, et al.. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathol Commun 2019;7:168. https://doi.org/10.1186/s40478-019-0811-6.Search in Google Scholar

34. Demirbilek, H, Arya, VB, Ozbek, MN, Houghton, JA, Baran, RT, Akar, M, et al.. Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations. Eur J Endocrinol 2015;172:697. https://doi.org/10.1530/eje-14-0852.Search in Google Scholar

35. Ijaz, S, Zahoor, MY, Imran, M, Ramzan, K, Bhinder, MA, Shakeel, H, et al.. Genetic analysis of fructose-1, 6-bisphosphatase (FBPase) deficiency in nine consanguineous Pakistani families. J Pediatr Endocrinol Metab 2017;30:1203–10. https://doi.org/10.1515/jpem-2017-0188.Search in Google Scholar

Received: 2020-11-23
Accepted: 2021-05-31
Published Online: 2021-06-30
Published in Print: 2021-09-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 24.5.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2020-0669/html
Scroll to top button